WRAP53 promotes cancer cell survival and is a potential target for cancer therapy

We previously identified WRAP53 as an antisense transcript that regulates the p53 tumor suppressor. The WRAP53 gene also encodes a protein essential for Cajal body formation and involved in cellular trafficking of the survival of motor neuron complex, the telomerase enzyme and small Cajal body-specific RNAs to Cajal bodies. Here, we show that the WRAP53 protein is overexpressed in a variety of cancer cell lines of different origin and that WRAP53 overexpression promotes cellular transformation. Knockdown of the WRAP53 protein triggers massive apoptosis through the mitochondrial pathway, as demonstrated by Bax/Bak activation, loss of mitochondrial membrane potential and cytochrome c release. The apoptosis induced by WRAP53 knockdown could moreover be blocked by Bcl-2 overexpression. Interestingly, human tumor cells are more sensitive to WRAP53 depletion as compared with normal human cells indicating that cancer cells in particular depends on WRAP53 expression for their survival. In agreement with this, we found that high levels of WRAP53 correlate with poor prognosis of head and neck cancer. Together these observations propose a role of WRAP53 in carcinogenesis and identify WRAP53 as a novel molecular target for a large fraction of malignancies.

[1]  G. Toth,et al.  Survival motor Neuron protein regulates apoptosis in anin vitro model of Spinal muscular atrophy , 2009, Neurotoxicity Research.

[2]  J. Gall,et al.  Cajal bodies: the first 100 years. , 2000, Annual review of cell and developmental biology.

[3]  R. Grafström,et al.  Multiple genotypic aberrances associate to terminal differentiation-deficiency of an oral squamous cell carcinoma in serum-free culture. , 2008, Differentiation; research in biological diversity.

[4]  Mark Sherman,et al.  Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer. , 2009, Cancer research.

[5]  S. Kyo,et al.  Understanding and exploiting hTERT promoter regulation for diagnosis and treatment of human cancers , 2008, Cancer science.

[6]  M. Blasco,et al.  Increased epidermal tumors and increased skin wound healing in transgenic mice overexpressing the catalytic subunit of telomerase, mTERT, in basal keratinocytes , 2001, The EMBO journal.

[7]  A. Gregory Matera,et al.  Residual Cajal bodies in coilin knockout mice fail to recruit Sm snRNPs and SMN, the spinal muscular atrophy gene product , 2001, The Journal of cell biology.

[8]  M. Wood,et al.  Knockdown of SMN by RNA interference induces apoptosis in differentiated P19 neural stem cells , 2007, Brain Research.

[9]  Katarzyna Sikora,et al.  Human telomerase RNA accumulation in Cajal bodies facilitates telomerase recruitment to telomeres and telomere elongation. , 2007, Molecular cell.

[10]  Robert Welch,et al.  Common genetic variation in TP53 and its flanking genes, WDR79 and ATP1B2, and susceptibility to breast cancer , 2007, International journal of cancer.

[11]  Julian Downward,et al.  Involvement of survival motor neuron (SMN) protein in cell death. , 2002, Human molecular genetics.

[12]  R. DePinho,et al.  Telomerase extracurricular activities , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[13]  J. Gall,et al.  Coilin is essential for Cajal body organization in Drosophila melanogaster. , 2009, Molecular biology of the cell.

[14]  Timothy D. Veenstra,et al.  A Human Telomerase Holoenzyme Protein Required for Cajal Body Localization and Telomere Synthesis , 2009, Science.

[15]  A. Pendle,et al.  A distant coilin homologue is required for the formation of cajal bodies in Arabidopsis. , 2006, Molecular biology of the cell.

[16]  H. Xu,et al.  Coilin levels and modifications influence artificial reporter splicing , 2008, Cellular and Molecular Life Sciences.

[17]  Angus I Lamond,et al.  Cajal bodies: a long history of discovery. , 2005, Annual review of cell and developmental biology.

[18]  M. Blasco,et al.  The telomerase RNA component Terc is required for the tumour‐promoting effects of Tert overexpression , 2005, EMBO reports.

[19]  Y. Hua,et al.  Inhibition of Apoptosis by Z-VAD-fmk in SMN-depleted S2 Cells* , 2003, Journal of Biological Chemistry.

[20]  J. Steitz,et al.  A conserved WD40 protein binds the Cajal body localization signal of scaRNP particles. , 2009, Molecular cell.

[21]  L. Chin,et al.  Telomerase reverse transcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation , 1999, Oncogene.

[22]  J. Shay,et al.  Actions of human telomerase beyond telomeres , 2008, Cell Research.

[23]  C. Laurell,et al.  Differential RNA Expression Profile by cDNA Microarray in Sporadic Primary Hyperparathyroidism (pHPT): Primary Parathyroid Hyperplasia versus Adenoma , 2006, World Journal of Surgery.

[24]  A. Protopopov,et al.  Telomerase inhibition by siRNA causes senescence and apoptosis in Barrett's adenocarcinoma cells: mechanism and therapeutic potential , 2005, Molecular Cancer.

[25]  A. Joe,et al.  Oncogene addiction. , 2008, Cancer research.

[26]  Liping Tian,et al.  Reduced Viability, Fertility and Fecundity in Mice Lacking the Cajal Body Marker Protein, Coilin , 2009, PloS one.

[27]  Yan Zhang,et al.  GEPIS - quantitative gene expression profiling in normal and cancer tissues , 2004, Bioinform..